Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo

Immunity

Volumn 13, Issue 4, 2000, Pages 423-431

  Cai, Zhongling ^a   De Bruijn, Marella ^c   Ma, Xiaoqian ^c   Dortland, Bjorn ^c   Luteijn, Tanya ^c   Downing, James R ^a,b   Dzierzak, Elaine ^c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN CBF BETA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; CELL TYPE; EMBRYO; FETUS LIVER; GENE MUTATION; GONAD; HAPLOTYPE; HEMATOPOIETIC STEM CELL; LETHALITY; MESONEPHROS; MOUSE; NONHUMAN; PRIORITY JOURNAL; YOLK SAC;

EID: 0033697669     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)00042-X     Document Type: Article

References (44)

1. Lineage- and stage-specific expression of runt box polypeptides in primitive and definitive hematopoiesis
2. Bone marrow cellular composition in Listeria monocytogenes infected mice detected using ER-MP12 and ER-MP20 antibodies: A flow cytometric alternative to differential counting
3. CFU-S11 activity does not localize solely with the aorta in the AGM region
4. Definitive hematopoietic stem cells first emerge from the major arterial regions of the mouse embryo
5. Diffuse intraembryonic hemopoiesis in normal and chimeric avian development
6. Runt determines cell fates in the Drosophila embryonic CNS
7. The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: Biology and clinical significance
8. Isolation and analysis of hematopoietic stem cells from mouse embryos
9. Potential intraembryonic hemogenic sites at pre-liver stages in the mouse
10. SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus
11. Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny
12. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer
13. Specification of drosophila hematopoietic lineage by conserved transcription factors
14. Core-binding factor influences the disease specificity of Moloney murine leukemia virus
15. Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers
16. Definitive hematopoiesis is autonomously initiated by the AGM region
17. An early pre-liver intraembryonic source of CFU-S in the developing mouse
18. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: The runt homology domain is required for DNA binding and protein-protein interactions
19. The AML1 transcription factor functions to develop and maintain hematogenic precursor cells in the embryonic aort-gonad-mesonephros region
20. ES cells have only a limited lymphopoietic potential after adoptive transfer into mouse recipients
21. Development of hematopoietic stem cell activity in the mouse embryo
22. Cbfα is required for the formation of intraaortic hematopoietic clusters
23. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells
24. Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha
25. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene
26. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis
27. A phorbol ester response element within the human T-cell receptor beta-chain enhancer
28. Characterization of the first definitive hematopoietic stem cells in the AGM and liver of the mouse embryo
29. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta
30. Expression of runt in the mouse embryo
31. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia
32. Purification and characterization of mouse hematopoietic stem cells
33. Mouse hematopoietic stem cells
34. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity
35. Core-binding factor: A central player in hematopoiesis and leukemia
36. Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2
37. Aorta-associated CD34+ hematopoietic cells in the early human embryo
38. A Xenopus homologue of aml-1 reveals unexpected patterning mechanisms leading to the formation of embryonic blood
39. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium
40. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor
41. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis
42. The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo
43. Multiple point mutations affecting the simian virus 40 enhancer
44. Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1)